Can ceftriaxone be combined with Augmentin (amoxicillin-clavulanate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Ceftriaxone Be Combined with Augmentin?

Yes, ceftriaxone and Augmentin (amoxicillin-clavulanate) can be safely combined and are specifically recommended together for certain serious infections, particularly endocarditis and severe community-acquired infections requiring broad antimicrobial coverage. 1

Guideline-Supported Clinical Scenarios

Specific Indications for Combination Therapy

  • Endocarditis: The American Heart Association recommends the combination of ampicillin (similar beta-lactam to amoxicillin) and ceftriaxone for a 6-week course for prosthetic valve endocarditis caused by penicillin-susceptible streptococcal strains and for aminoglycoside-nonsusceptible Enterococcus faecalis strains. 1

  • Moderate-to-Severe Intra-Abdominal Infections: The European Society of Clinical Microbiology and Infectious Diseases recommends considering combination therapy when broad coverage is needed for moderate to severe intra-abdominal infections. 1

  • Acute Bacterial Rhinosinusitis: The American Academy of Otolaryngology-Head and Neck Surgery suggests considering combination therapy with adequate gram-positive and gram-negative coverage for adults with moderate acute bacterial rhinosinusitis or those who have received antibiotics in the previous 4-6 weeks. 2, 1

  • Febrile Neutropenia: The Infectious Diseases Society of America recommends combination therapy with ciprofloxacin combined with amoxicillin-clavulanic acid for low-risk neutropenic patients, demonstrating that beta-lactam combinations are appropriate in specific contexts. 2

Evidence of Synergy

  • Experimental data demonstrates that the combination of amoxicillin and ceftriaxone is strongly synergic against penicillin-resistant and cephalosporin-resistant Streptococcus pneumoniae, with fractional inhibitory concentration indexes showing additive effects (1.1-1.3) and significantly higher bacterial reductions in animal models compared to single-drug regimens. 3

Important Safety Considerations

Monitoring Requirements

  • Nephrotoxicity: The American Heart Association advises monitoring for nephrotoxicity, especially if other nephrotoxic agents are being used concurrently with multiple beta-lactam antibiotics. 1

  • Hypersensitivity Reactions: The American Academy of Otolaryngology-Head and Neck Surgery recommends monitoring for hypersensitivity reactions, as cross-reactivity may occur between different beta-lactams. 1

  • Superinfection: The European Society of Clinical Microbiology and Infectious Diseases suggests monitoring for superinfection with resistant organisms when using combination therapy. 1

Practical Administration Guidelines

How to Administer

  • Separate Administration: The European Society of Clinical Microbiology and Infectious Diseases recommends administering these medications separately, without mixing in the same IV bag or syringe, and flushing IV lines between administrations of different antibiotics. 1

Duration of Therapy

  • Endocarditis: The American Heart Association recommends 6 weeks of combination therapy. 1

  • Other Infections: The European Society of Clinical Microbiology and Infectious Diseases suggests that duration depends on the specific indication, severity, and clinical response. 1

Coverage Spectrum

What This Combination Covers

  • Both agents provide excellent activity against Streptococcus pneumoniae, including penicillin-resistant strains when combined. 4, 3

  • Ceftriaxone has good activity against Haemophilus influenzae, Moraxella catarrhalis, Neisseria species, and Enterobacteriaceae. 4

  • Augmentin extends coverage to include beta-lactamase-producing strains of Staphylococcus aureus (methicillin-susceptible), Haemophilus influenzae, Escherichia coli, and anaerobes including Bacteroides fragilis. 5

Coverage Gaps

  • Neither agent provides reliable coverage against Pseudomonas aeruginosa—if suspected, use antipseudomonal agents like piperacillin-tazobactam or cefepime instead. 2

  • This combination does not cover methicillin-resistant Staphylococcus aureus (MRSA)—add vancomycin or linezolid if MRSA is suspected. 6

Antimicrobial Stewardship Considerations

  • The use of broad-spectrum combinations like Augmentin and ceftriaxone should be reserved for specific indications where necessary, rather than used routinely, to promote antimicrobial stewardship and prevent resistance. 7

  • Inappropriate use of broad-spectrum combinations can promote antimicrobial resistance. 7

References

1
Guideline

Co-administration of Ampicillin-Sulbactam and Ceftriaxone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

5
Research

Augmentin: laboratory studies.

Scottish medical journal, 1982

6
Guideline

Antimicrobial Combination Therapy with Cefuroxime, Azithromycin, and Fluconazole

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

7
Guideline

Combination Therapy with Augmentin and Ciprofloxacin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What antibiotic should be used for a 73-year-old patient with potential pneumonia?
What is the cause of post-operative pain and hardening around the surgical site in a 76-year-old male following thrombectomy for Pulmonary Embolism (PE) removal?
What is the diagnosis and treatment for a 7-year-old with Haemophilus (H. influenzae) infection?
What is the most appropriate diagnostic imaging study for a 12-year-old patient with periorbital (around the eye) redness and swelling, proptosis (bulging of the eye) of the left eye, impaired and painful left extraocular movements, nasal congestion, facial pressure, and cough?
What alternative antibiotic (Abx) can be given to a 1.5-year-old not responding to cefdinir (Cediranib is not an antibiotic, assuming cefdinir) after 3 days?
What causes excessive sweating in a patient with End-Stage Renal Disease (ESRD) when eating?
What is the appropriate management for a patient presenting with petechia, leg edema, and back pain?
When should the gallbladder be removed in adults with gallstone disease?
What are the clinical implications of a new study for clinical practice recommendations?
What is the comparative efficacy and safety of dupilumab (Dupixent) vs tralokinumab, lebrikizumab, oral Janus kinase (JAK) inhibitors (abrocitinib, upadacitinib, baricitinib), and methotrexate for severe or refractory asthma?
How often should blood glucose levels be monitored in patients with acute pancreatitis who are NPO (nil per os)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question